Medidata Solutions, Inc. (MDSO) to Release Quarterly Earnings on Monday
Medidata Solutions, Inc. (NASDAQ:MDSO) is set to announce its earnings results before the market opens on Monday, October 23rd. Analysts expect the company to announce earnings of $0.31 per share for the quarter.
Medidata Solutions, Inc. (MDSO) opened at 81.08 on Friday. The company has a 50 day moving average price of $77.55 and a 200-day moving average price of $73.79. Medidata Solutions, Inc. has a 12-month low of $46.10 and a 12-month high of $85.92. The company has a market capitalization of $4.59 billion, a PE ratio of 130.99 and a beta of 1.77.
In other Medidata Solutions news, COO Michael L. Capone sold 5,000 shares of the stock in a transaction dated Tuesday, August 15th. The stock was sold at an average price of $74.53, for a total value of $372,650.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 5.80% of the stock is currently owned by company insiders.
Several analysts recently weighed in on MDSO shares. SunTrust Banks, Inc. upped their price objective on Medidata Solutions from $80.00 to $90.00 and gave the stock a “buy” rating in a research report on Tuesday, June 27th. Piper Jaffray Companies upped their price objective on Medidata Solutions to $87.00 and gave the stock an “overweight” rating in a research report on Friday, July 7th. Citigroup Inc. restated a “buy” rating and set a $94.00 price objective (up from $77.00) on shares of Medidata Solutions in a research report on Monday, July 10th. J P Morgan Chase & Co upped their price objective on Medidata Solutions to $87.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 18th. Finally, Morgan Stanley upped their price objective on Medidata Solutions from $74.00 to $86.00 and gave the stock an “overweight” rating in a research report on Thursday, July 20th. Four analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Medidata Solutions currently has an average rating of “Buy” and an average price target of $84.64.
About Medidata Solutions
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Receive News & Stock Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related stocks with our FREE daily email newsletter.